Terms: = Endocrine gland cancer AND AKAP9, AKAP350, 10142, ENSG00000127914, KIAA0803, Q99996, AKAP450, YOTIAO, PRKA9, HYPERION, MU-RMS-40_16A, CG-NAP
23 results:
1. Expression of
Soboska K; Kusiński M; Pawelczyk K; Migdalska-Sęk M; Brzeziańska-Lasota E; Czarnecka-Chrebelska KH
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203733
[TBL] [Abstract] [Full Text] [Related]
2. Intronic Germline
Fraire CR; Mallinger PR; Hatton JN; Kim J; Dickens DS; Argenta PA; Milanovich S; Hartshorne T; Carey DJ; Haley JS; Urban G; Lee J; Hill DA; Stewart DR; Schultz KAP; Chen KS
JCO Precis Oncol; 2023 Sep; 7():e2300189. PubMed ID: 37883719
[TBL] [Abstract] [Full Text] [Related]
3. Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian cancer Treated With Carboplatin, Taxane, and Bevacizumab.
Polano M; Bedon L; Dal Bo M; Sorio R; Bartoletti M; De Mattia E; Cecchin E; Pisano C; Lorusso D; Lissoni AA; De Censi A; Cecere SC; Scollo P; Marchini S; Arenare L; De Giorgi U; Califano D; Biagioli E; Chiodini P; Perrone F; Pignata S; Toffoli G
Clin Pharmacol Ther; 2023 Sep; 114(3):652-663. PubMed ID: 37243926
[TBL] [Abstract] [Full Text] [Related]
4. Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.
Forlani L; De Cecco L; Simeon V; Paolini B; Bagnoli M; Cecere SC; Spina A; Citeroni E; Bignotti E; Lorusso D; Arenare L; Russo D; De Angelis C; Ardighieri L; Scognamiglio G; Del Sesto M; Tognon G; Califano D; Schettino C; Chiodini P; Perrone F; Mezzanzanica D; Pignata S; Tomassetti A
J Exp Clin Cancer Res; 2023 Apr; 42(1):83. PubMed ID: 37041632
[TBL] [Abstract] [Full Text] [Related]
5. State Trends of Cannabis Liberalization as a Causal Driver of Increasing Testicular cancer Rates across the USA.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232059
[TBL] [Abstract] [Full Text] [Related]
6. Stress, Thyroid Dysregulation, and Thyroid cancer in Children and Adolescents: Proposed Impending Mechanisms.
Kyriacou A; Tziaferi V; Toumba M
Horm Res Paediatr; 2023; 96(1):44-53. PubMed ID: 35385843
[TBL] [Abstract] [Full Text] [Related]
7. Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.
Di Liello R; Arenare L; Raspagliesi F; Scambia G; Pisano C; Colombo N; Frezzini S; Tognon G; Artioli G; Gadducci A; Lauria R; Ferrero A; Cinieri S; De Censi A; Breda E; Scollo P; De Giorgi U; Lissoni AA; Katsaros D; Lorusso D; Salutari V; Cecere SC; Lapresa M; Nardin M; Bogani G; Distefano M; Greggi S; Gargiulo P; Schettino C; Gallo C; Daniele G; Califano D; Perrone F; Pignata S; Piccirillo MC
Int J Gynecol Cancer; 2021 Oct; 31(10):1348-1355. PubMed ID: 34462317
[TBL] [Abstract] [Full Text] [Related]
8. Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
Daniele G; Raspagliesi F; Scambia G; Pisano C; Colombo N; Frezzini S; Tognon G; Artioli G; Gadducci A; Lauria R; Ferrero A; Cinieri S; De Censi A; Breda E; Scollo P; De Giorgi U; Lissoni AA; Katsaros D; Lorusso D; Salutari V; Cecere SC; Zaccarelli E; Nardin M; Bogani G; Distefano M; Greggi S; Piccirillo MC; Fossati R; Giannone G; Arenare L; Gallo C; Perrone F; Pignata S
Int J Gynecol Cancer; 2021 Jun; 31(6):875-882. PubMed ID: 33931498
[TBL] [Abstract] [Full Text] [Related]
9. Sestamibi Single-Positron Emission Computed Tomography/Diagnostic-quality Computed Tomography for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism: What clinicopathologic factors affect its accuracy?
Yang J; Wang H; Zhang J; Xu W; Weng W; Lv S; Dong M
J Endocrinol Invest; 2021 Aug; 44(8):1649-1658. PubMed ID: 33393058
[TBL] [Abstract] [Full Text] [Related]
10. Codon bias analyses on thyroid carcinoma genes.
Pepe D; DE Keersmaecker K
Minerva Endocrinol; 2020 Dec; 45(4):295-305. PubMed ID: 33103872
[TBL] [Abstract] [Full Text] [Related]
11. Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.
Daniele G; Lorusso D; Scambia G; Cecere SC; Nicoletto MO; Breda E; Colombo N; Artioli G; Cannella L; Lo Re G; Raspagliesi F; Maltese G; Salutari V; Ferrandina G; Greggi S; Baldoni A; Bergamini A; Piccirillo MC; Tognon G; Floriani I; Signoriello S; Perrone F; Pignata S
Gynecol Oncol; 2017 Feb; 144(2):256-259. PubMed ID: 27993479
[TBL] [Abstract] [Full Text] [Related]
12. [Radical antegrade modular pancreatosplenectomy procedure in pancreatic body/tail adenocarcinoma].
Cao F; Oba T; Saiura P; Li F
Zhonghua Wai Ke Za Zhi; 2016 Nov; 54(11):833-838. PubMed ID: 27806776
[TBL] [Abstract] [Full Text] [Related]
13. HRAS mutation prevalence and associated expression patterns in pheochromocytoma.
Stenman A; Welander J; Gustavsson I; Brunaud L; Bäckdahl M; Söderkvist P; Gimm O; Juhlin CC; Larsson C
Genes Chromosomes Cancer; 2016 May; 55(5):452-9. PubMed ID: 26773571
[TBL] [Abstract] [Full Text] [Related]
14. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ganly I; Ricarte Filho J; Eng S; Ghossein R; Morris LG; Liang Y; Socci N; Kannan K; Mo Q; Fagin JA; Chan TA
J Clin Endocrinol Metab; 2013 May; 98(5):E962-72. PubMed ID: 23543667
[TBL] [Abstract] [Full Text] [Related]
15. Frequency of close positioning of chromosomal loci detected by FRET correlates with their participation in carcinogenic rearrangements in human cells.
Gandhi M; Evdokimova V; Nikiforov YE
Genes Chromosomes Cancer; 2012 Nov; 51(11):1037-44. PubMed ID: 22887574
[TBL] [Abstract] [Full Text] [Related]
16. Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia.
Caria P; Vanni R
Cancer Genet Cytogenet; 2010 Nov; 203(1):21-9. PubMed ID: 20951315
[TBL] [Abstract] [Full Text] [Related]
17. Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.
Gandhi M; Evdokimova V; Nikiforov YE
Mol Cell Endocrinol; 2010 May; 321(1):36-43. PubMed ID: 19766698
[TBL] [Abstract] [Full Text] [Related]
18. Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo.
Giamas G; Hirner H; Shoshiashvili L; Grothey A; Gessert S; Kühl M; Henne-Bruns D; Vorgias CE; Knippschild U
Biochem J; 2007 Sep; 406(3):389-98. PubMed ID: 17594292
[TBL] [Abstract] [Full Text] [Related]
19. BRAF mutation and akap9 expression in sporadic papillary thyroid carcinomas.
Lee JH; Lee ES; Kim YS; Won NH; Chae YS
Pathology; 2006 Jun; 38(3):201-4. PubMed ID: 16753739
[TBL] [Abstract] [Full Text] [Related]
20. Alterations of the BRAF gene in thyroid tumors.
Ciampi R; Nikiforov YE
Endocr Pathol; 2005; 16(3):163-72. PubMed ID: 16299399
[TBL] [Abstract] [Full Text] [Related]
[Next]
